209106976 | UGH | 00907967 | | 6930344 | 8/20/2005 12:00:00 AM | congestive heart failure | | DIS | Admission Date : 7/15/2005 Report Status : Discharge Date : 11/20/2005 ****** FINAL DISCHARGE ORDERS ****** MACCARINO , BURL J 100-68-32-5 Lum Van Vallille Service : CAR DISCHARGE PATIENT ON : 5/23/05 AT 12:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY : YES Attending : TIMBERLAKE , MONROE SHANE , M.D. , B.CH . 
CODE STATUS : Full code DISPOSITION : Home w / services DISCHARGE MEDICATIONS : ALLOPURINOL 200 MG PO QD COLCHICINE 0.6 MG PO QD COLACE -LRB- DOCUSATE SODIUM -RRB- 100 MG PO BID FERROUS SULFATE 325 MG PO TID Food/Drug Interaction Instruction Avoid milk and antacid FOLATE -LRB- FOLIC ACID -RRB- 1 MG PO QD LASIX -LRB- FUROSEMIDE -RRB- 200 MG PO QD ZAROXOLYN -LRB- METOLAZONE -RRB- 2.5 MG PO 3x/Week M-W-F Starting Today -LRB- 11/25 -RRB- METOPROLOL TARTRATE 25 MG PO BID Food/Drug Interaction Instruction Take consistently with meals or on empty stomach . 
OXYCODONE 5 MG PO Q8H Starting Today -LRB- 11/25 -RRB- PRN Pain PHENOBARBITAL 180 MG PO TID Starting Today -LRB- 11/25 -RRB- SENNA TABLETS -LRB- SENNOSIDES -RRB- 2 TAB PO QHS OXYCONTIN -LRB- OXYCODONE CONTROLLED RELEASE -RRB- 20 MG PO Q12H LANTUS -LRB- INSULIN GLARGINE -RRB- 38 UNITS SC QHS ECASA -LRB- ASPIRIN ENTERIC COATED -RRB- 81 MG PO QD ATORVASTATIN 10 MG PO QD COUMADIN -LRB- WARFARIN SODIUM -RRB- 15 MG PO QPM Starting ROUTINE , 20:00 -LRB- Standard Admin Time -RRB- Instructions : Take 15 mg twice per week only . 
Food/Drug Interaction Instruction No high Vitamin-K containing foods Alert overridden : Override added on 5/23/05 by : SERIOUS INTERACTION : ALLOPURINOL & WARFARIN POTENTIALLY SERIOUS INTERACTION : SIMVASTATIN & WARFARIN POTENTIALLY SERIOUS INTERACTION : ASPIRIN & WARFARIN POTENTIALLY SERIOUS INTERACTION : PHENOBARBITAL & WARFARIN POTENTIALLY SERIOUS INTERACTION : PHENOBARBITAL & WARFARIN Reason for override : patient 's home regimen COUMADIN -LRB- WARFARIN SODIUM -RRB- 12.5 MG PO QPM Starting ROUTINE , 20:00 -LRB- Standard Admin Time -RRB- Instructions : Take 12.5 mg five times per week Food/Drug Interaction Instruction No high Vitamin-K containing foods Alert overridden : Override added on 5/23/05 by : SERIOUS INTERACTION : ALLOPURINOL & WARFARIN POTENTIALLY SERIOUS INTERACTION : SIMVASTATIN & WARFARIN POTENTIALLY SERIOUS INTERACTION : ASPIRIN & WARFARIN POTENTIALLY SERIOUS INTERACTION : PHENOBARBITAL & WARFARIN POTENTIALLY SERIOUS INTERACTION : PHENOBARBITAL & WARFARIN Reason for override : patient 's home regimen MAGNESIUM GLUCONATE 500 MG PO BID KCL SLOW RELEASE 20 MEQ PO QD As per TLH Potassium Chloride Policy : each 20 mEq dose to be given with 4 oz of fluid INSULIN LISPRO SC Instructions : AC and QHS as directed DIET : Patient should measure weight daily DIET : Fluid restriction : 2 liters DIET : House / Low chol/low sat . 
fat DIET : 2 gram Sodium ACTIVITY : Walking as tolerated FOLLOW UP APPOINTMENT -LRB- S -RRB- : Dr. Tausch 4/5 3:00 pm scheduled , Coumadin clinic , Dr. Witwer call to schedule 1-2 weeks , Arrange INR to be drawn on 9/8/05 with f/u INR 's to be drawn every 7 days . 
INR 's will be followed by Coumadin Clinic ALLERGY : MEPERIDINE HCL , SILDENAFIL CITRATE , GABAPENTIN , SPIRONOLACTONE , NITRATE , DIGOXIN , AMLODIPINE ADMIT DIAGNOSIS : congestive heart failure PRINCIPAL DISCHARGE DIAGNOSIS ; Responsible After Study for Causing Admission -RRB- congestive heart failure OTHER DIAGNOSIS ; Conditions , Infections , Complications , affecting Treatment/Stay VV pacer -LRB- pacemaker -RRB- CAD s/p CABG -LRB- coronary artery disease -RRB- CHF -LRB- congestive heart failure -RRB- Afib -LRB- atrial fibrillation -RRB- CVA -LRB- cerebrovascular accident -RRB- IDDM -LRB- diabetes mellitus -RRB- Peripheral neuropathy -LRB- peripheral neuropathy -RRB- Obesity -LRB- obesity -RRB- PVD -LRB- peripheral vascular disease -RRB- CRI -LRB- chronic renal dysfunction -RRB- OPERATIONS AND PROCEDURES : none OTHER TREATMENTS/PROCEDURES -LRB- NOT IN O.R. -RRB- none BRIEF RESUME OF HOSPITAL COURSE : HPI : 70 yo man MMP including ischemic CMP CAD s/p CABG , CRI , A-fib/BiV PM - multiple hospitalizations for CHF exacerbation - presents w 1-2 weeks worsening dyspnea . 
Recently restarted on lisinopril - became hyperkalemic - lasix and zaroxolyn were decreased . 
Pt denied any CP , fevers , palpitations , lightheadness , dizziness . 
No AICD firing . 
PMH : as above - ho CVA w word finding difficulties - Admit Labs : Cr 1.4 K 4.5 trop neg No EKG changes - V paced , LBBB , LAD VSS BP 130/70 HR 80 100 % RA , NAD - word finding difficultues - JVP 15 + , chest CTA , HRT 2/6 harsh SEM at apex rad to LUSB + s3 , ext 2-3 + PE L > R - motor/sensory intact - no deficits CXR : stable cardiomegaly , new mass in RUL labs : cr 1.4 -LRB- 2.3 on 9/21 -RRB- , CK 128 CKMB :7.3 trop flat Course : In ED given 60 IV lasix , put out 700cc . 
all : multiple SH : smoker in past A/P : 70 Yo ischemic CMP w decompensated CHF in the setting of recent change in diuretic regimen . 
CV : fluid overloaded - back to dry weight with IV Lasix -LRB- 114 lbs -RRB- . 
ACE inh was discontinued . 
Echo : EF 55 % - w mod MR , mild AS . 
I : known ho CAD - ruled out for MI R : ho A-fib , V paced - on coumadin - held initially for INR > 3 , then re-started home dose since 2.6 on day of discharge . 
PM NEURO : ho CVA - on phenobarbitol RENAL : diabetes , hyperkalemia : Held ACE and watched lytes on IV lasix . 
Cr and electrolytes stable throughout hospitalization . 
DNR-not DNI ADDITIONAL COMMENTS : You should re-start your coumadin this evening , and follow-up with the coumadin clinic . 
Please continue to do daily weights . 
DISCHARGE CONDITION : Stable TO DO/PLAN : Needs outpt CT to evaluate RUL mass . 
Has outpatient ECHO scheduled . 
No dictated summary ENTERED BY : STOVER , FABIAN R. , M.D. , PH.D. -LRB- TI919 -RRB- 5/23/05 @ 12:00 PM ****** END OF DISCHARGE ORDERS ****** 
